Article Text

Download PDFPDF

Randomised Evaluation of modified Valsalva Effectiveness in Re-entrant Tachycardias (REVERT) study
  1. Andrew Appelboam1,
  2. Adam Reuben1,
  3. Clifford Mann2,
  4. Trudie Lobban3,
  5. Paul Ewings4,
  6. Jonathan Benger5,
  7. Jane Vickery6,
  8. Andrew Barton6,
  9. James Gagg2
  1. 1Department of Emergency Medicine, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, Devon, UK
  2. 2Department of Emergency Medicine, Musgrove Park Hospital NHS Foundation Trust, Taunton, UK
  3. 3Arrhythmia Alliance, Stratford-upon-Avon, UK
  4. 4Research Design Service South West, University of Exeter Medical School, Taunton, UK
  5. 5Faculty of Health and Life Sciences, University of the West of England, Bristol, UK
  6. 6Peninsula Clinical Trials Unit, Plymouth University, Plymouth, UK
  1. Correspondence to Dr Andrew Appelboam; andy.appelboam{at}


Introduction The Valsalva manoeuvre (VM) is a recommended first-line physical treatment for patients with re-entrant supraventricular tachycardia (SVT), but is often ineffective in standard practice. A failed VM is typically followed by treatment with intravenous adenosine, which patients often find unpleasant. VM effectiveness might be improved by a modification to posture which exaggerates the manoeuvre's vagal response and reduces the need for further emergency treatment.

Methods and analysis This is a multicentre randomised controlled clinical trial in 10 UK emergency departments (EDs). It compares a standard VM with a modified VM incorporating leg elevation and a supine posture after a standardised strain in stable adult patients presenting to the ED with SVT. The primary outcome measure is return to sinus rhythm on a 12-lead ECG. Secondary outcome measures include the need for treatment with adenosine or other antiarrhythmic treatments and the time patients spend in the ED. We plan to recruit approximately 372 patients, with 80% power to demonstrate an absolute improvement in cardioversion rate of 12%. An improvement of this magnitude through the use of a modified VM would be of significant benefit to patients and healthcare providers, and justify a change to standard practice.

Ethics and dissemination The study has been approved by the South West—Exeter Research Ethics Committee (REC reference 12/SW/0281). The trial will be published in an international peer reviewed journal. Study findings will be sent to the European and International resuscitation councils to inform future revisions of arrhythmia management guidelines.

Results The trial will also be disseminated at international conferences and to patients through the Arrhythmia Alliance, a patient support charity.

Registration The study is registered with Current Controlled Trials (ISRCTN67937027) and has been adopted by the National Institute for Health Research (NIHR) Clinical Research Network.

  • Accident & Emergency Medicine

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.